Atorvastatin News
Dr Reddy's launches Atocor-R in India
Pharmaceutical major Dr Reddy's Laboratories on Thursday announced the launch of a drug 'Atocor-R', a combination of Atorvastatin and Ramipril, used in the treatment of cardiavascular disease, in the domestic market.
Ranbaxy gets mixed verdict on Pfizer’s Lipitor in Australia
In a partial victory for Ranbaxy Laboratories in its patent litigation against Pfizer, an Australian court has ruled in favour of the Indian company in a case relating to Atorvastatin, the world’s largest selling...
Aggressive Cholesterol Control Benefits Bypass Patients
Clinical studies have suggested that intensive lowering of low-density lipoprotein (LDL) cholesterol, the 'bad' cholesterol, benefits certain groups of patients with chronic diseases, such as diabetes.
AMA Backs FDA Pre-Screening of Direct-to-Consumer TV Drug Ads
The American Medical Association, testifying before Congress, has endorsed the proposal that the FDA should review and approve all direct-to-consumer ads for new drugs before they are aired on television.
LifeCycle Pharma Announces Positive Data from LCP-AtorFen Phase II Clinical Program
LifeCycle Pharma successfully completes Phase II LCP-AtorFen clinical program and expects to initiate Phase III clinical program in 2H 2008 while simultaneously seeking a partner for completion of the Phase III clinical trial...